Representative Josh Gottheimer (D-New Jersey) recently sold shares of Intuitive Surgical, Inc. (NASDAQ:ISRG). In a filing disclosed on May 14th, the Representative disclosed that they had sold between $1,001 and $15,000 in Intuitive Surgical stock on April 9th. The trade occurred in the Representative’s “MORGAN STANLEY – SELECT UMA ACCOUNT # 1” account.
Representative Josh Gottheimer also recently made the following trade(s):
- Purchased $1,001 – $15,000 in shares of RTX (NYSE:RTX) on 4/23/2025.
- Purchased $1,001 – $15,000 in shares of Cheniere Energy (NYSE:LNG) on 4/22/2025.
- Purchased $1,001 – $15,000 in shares of Techtronic Industries (OTCMKTS:TTNDY) on 4/21/2025.
- Purchased $1,001 – $15,000 in shares of Tri Pointe Homes (NYSE:TPH) on 4/21/2025.
- Purchased $1,001 – $15,000 in shares of Perusahaan Perseroan (Persero) PT Telekomunikasi Indonesia Tbk (NYSE:TLK) on 4/21/2025.
- Sold $1,001 – $15,000 in shares of KKR & Co. Inc. (NYSE:KKR) on 4/21/2025.
- Purchased $1,001 – $15,000 in shares of D.R. Horton (NYSE:DHI) on 4/21/2025.
- Purchased $1,001 – $15,000 in shares of Home Depot (NYSE:HD) on 4/21/2025.
- Sold $1,001 – $15,000 in shares of Hillman Solutions (NASDAQ:HLMN) on 4/17/2025.
- Sold $1,001 – $15,000 in shares of AbbVie (NYSE:ABBV) on 4/17/2025.
Intuitive Surgical Trading Down 1.0%
Shares of ISRG opened at $560.28 on Friday. The firm has a market cap of $200.81 billion, a P/E ratio of 87.41, a PEG ratio of 5.85 and a beta of 1.70. Intuitive Surgical, Inc. has a 12 month low of $393.98 and a 12 month high of $616.00. The stock’s 50 day moving average is $503.82 and its two-hundred day moving average is $536.13.
Insiders Place Their Bets
In other Intuitive Surgical news, Director Jami K. Nachtsheim sold 2,400 shares of Intuitive Surgical stock in a transaction dated Thursday, May 1st. The stock was sold at an average price of $520.00, for a total value of $1,248,000.00. Following the completion of the sale, the director now owns 6,371 shares in the company, valued at $3,312,920. The trade was a 27.36% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, EVP Brian Edward Miller sold 8,900 shares of the company’s stock in a transaction dated Tuesday, March 11th. The shares were sold at an average price of $485.07, for a total transaction of $4,317,123.00. Following the transaction, the executive vice president now directly owns 5,758 shares of the company’s stock, valued at approximately $2,793,033.06. This represents a 60.72% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 32,680 shares of company stock valued at $16,854,345. Company insiders own 0.70% of the company’s stock.
Analyst Upgrades and Downgrades
ISRG has been the subject of a number of recent research reports. Jefferies Financial Group raised their target price on Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. CICC Research started coverage on shares of Intuitive Surgical in a research report on Monday, January 27th. They set a “neutral” rating and a $550.00 price objective for the company. Royal Bank of Canada reduced their target price on shares of Intuitive Surgical from $630.00 to $605.00 and set an “outperform” rating on the stock in a research note on Wednesday, April 23rd. UBS Group increased their price target on shares of Intuitive Surgical from $500.00 to $560.00 and gave the company a “neutral” rating in a research note on Monday, January 27th. Finally, Leerink Partners lifted their price target on shares of Intuitive Surgical from $490.00 to $548.00 in a research report on Monday, January 27th. Five research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $598.95.
Check Out Our Latest Stock Report on ISRG
Hedge Funds Weigh In On Intuitive Surgical
A number of institutional investors have recently made changes to their positions in the stock. Atala Financial Inc purchased a new position in Intuitive Surgical in the 4th quarter valued at about $25,000. Chilton Capital Management LLC raised its position in shares of Intuitive Surgical by 614.3% in the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 43 shares during the last quarter. Berbice Capital Management LLC acquired a new position in shares of Intuitive Surgical in the fourth quarter valued at approximately $26,000. Parvin Asset Management LLC purchased a new position in shares of Intuitive Surgical during the fourth quarter valued at approximately $26,000. Finally, Global Financial Private Client LLC boosted its position in Intuitive Surgical by 253.3% during the first quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider’s stock worth $26,000 after acquiring an additional 38 shares during the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.
About Representative Gottheimer
Josh Gottheimer (Democratic Party) is a member of the U.S. House, representing New Jersey’s 5th Congressional District. He assumed office on January 3, 2017. His current term ends on January 3, 2027.
Gottheimer (Democratic Party) is running for re-election to the U.S. House to represent New Jersey’s 5th Congressional District. He declared candidacy for the 2026 election.
Gottheimer is also running for election for Governor of New Jersey. He declared candidacy for the Democratic primary scheduled on June 10, 2025.
Gottheimer attended the University of Pennsylvania for his undergraduate degree. He became a Thouron Fellow at Oxford and attended Harvard Law School. Gottheimer worked as a speech writer under former President Bill Clinton (D), assisting with two State of the Union addresses, among other projects. Before running for Congress, he worked for Microsoft as a general manager for corporate strategy.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
See Also
- Five stocks we like better than Intuitive Surgical
- Growth Stocks: What They Are, Examples and How to Invest
- Walmart Stock Alert: Big Price Move Expected Soon
- How to Invest in Small Cap Stocks
- An Acquisition Just Made Dick’s the Most Exciting Stock in Retail
- Differences Between Momentum Investing and Long Term Investing
- Microsoft and OpenAI Just Hit Reset—Here’s Why MSFT Stock Wins
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.